Samsung BioLogics

[Not Yet Scheduled]
As a global CDMO, Samsung BioLogics provides biologics' development and manufacturing services as well as newly launched CRO service. we provide our CDO services ranging from generating stable cell line to cGMP manufacturing and IND filing support with faster timeline and better quality.
Ticker:
207940
Exchange:
KRW
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Korea - South Korea
Year Founded:
Not Provided
Main Therapeutic Focus:
Lead Product in Development:
Contract Development Service
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Part Leader
Samsung BioLogics